Afya (AFYA) Cash And Cash Equivalents : $122.7 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Afya Cash And Cash Equivalents?

Afya's quarterly cash and cash equivalents declined from Sep. 2023 ($166.44 Mil) to Dec. 2023 ($112.87 Mil) but then increased from Dec. 2023 ($112.87 Mil) to Mar. 2024 ($122.71 Mil).

Afya's annual cash and cash equivalents increased from Dec. 2021 ($132.37 Mil) to Dec. 2022 ($208.39 Mil) but then declined from Dec. 2022 ($208.39 Mil) to Dec. 2023 ($112.87 Mil).

Afya Cash And Cash Equivalents Historical Data

The historical data trend for Afya's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Afya Cash And Cash Equivalents Chart

Afya Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

Get a 7-Day Free Trial

229.80

203.13

132.37

208.39

112.87

Afya Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash And Cash Equivalents	Get a 7-Day Free Trial															138.75	152.71	166.44	112.87	122.71

Afya Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Afya (NAS:AFYA) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Afya Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Afya's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Afya (AFYA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Education » Afya Ltd (NAS:AFYA) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

1AY:Germany 1AY:Germany A2FY34:Brazil

Address

Alameda Oscar Niemeyer, No. 119, Room 504, Vila da Serra, Nova Lima, MG, BRA

Website

https://www.afya.com.br

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medicine, other health sciences, and other undergraduate programs, Continuing Education provides specialization programs and graduate courses in medicine; and Digital Services provides content and technology for medical education, clinical decisions software, practice management tools (that encompass electronic medical records, telemedicine, and digital prescription, and provides access, demand and efficiency for the healthcare players.